Oligonucleotide-mediated gene therapy for muscular dystrophies
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 12, S55-S60
- https://doi.org/10.1016/s0960-8966(02)00083-4
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Dystrophin Gene Repair in mdx Muscle Precursor Cells In Vitro and In Vivo Mediated by RNA-DNA Chimeric OligonucleotidesHuman Gene Therapy, 2002
- The potential of nucleic acid repair in functional genomicsNature Biotechnology, 2001
- Targeted gene correction by small single-stranded oligonucleotides in mammalian cellsGene Therapy, 2001
- Targeted Correction of a Defective Selectable Marker Gene in Human Epithelial Cells by Small DNA FragmentsMolecular Therapy, 2001
- Gene targeting via triple-helix formationProgress in Nucleic Acid Research and Molecular Biology, 2001
- Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotidesProceedings of the National Academy of Sciences, 2000
- Gene Correction by RNA-DNA OligonucleotidesPigment Cell Research, 2000
- Spliceosome-mediated RNA trans-splicing as a tool for gene therapyNature Biotechnology, 1999
- Gene Repair Using Chimeric RNA/DNA OligonucleotidesSeminars in Liver Disease, 1999
- Ribozyme trans–splicing and RNA tagging: Following the messengerNature Medicine, 1996